RBLX Q1 2026 Earnings Narrower Loss Surprises Analysts as Engagement Metrics Improve Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline BCML Q1 2026 Earnings Profit Beats Estimates by 226 on Strong Operating Performance Sera Prognostics Q1 2026 Earnings EPS Matches Estimates Stock Surges 15 on Strategic Progress SEGG Q1 2025 Earnings Loss Per Share Reported at 014 Stock Declines 545 APVO Q1 2026 Earnings EPS Miss Widens as Revenue Remains Absent